As of 2025-01-14, the Relative Valuation of Eli Lilly and Co (LLY) is 289.81 USD. This relative valuation is based on P/E multiples. With the latest stock price at 797.48 USD, the upside of Eli Lilly and Co based on Relative Valuation is -63.7%.
The range of the Relative Valuation is 233.90 - 330.23 USD.
| Range | Selected | |
| Trailing P/E multiples | 30.5x - 36.5x | 33.3x |
| Forward P/E multiples | 33.1x - 46.8x | 40.5x |
| Fair Price | 233.90 - 330.23 | 289.81 |
| Upside | -70.7% - -58.6% | -63.7% |
| Date | P/E |
| 2025-01-10 | 90.73 |
| 2025-01-08 | 89.29 |
| 2025-01-07 | 87.71 |
| 2025-01-06 | 86.78 |
| 2025-01-03 | 88.69 |
| 2025-01-02 | 88.25 |
| 2024-12-31 | 87.56 |
| 2024-12-30 | 87.77 |
| 2024-12-27 | 88.83 |
| 2024-12-26 | 90.07 |
| 2024-12-24 | 90.25 |
| 2024-12-23 | 90.31 |
| 2024-12-20 | 87.08 |
| 2024-12-19 | 85.92 |
| 2024-12-18 | 86.73 |
| 2024-12-17 | 88.31 |
| 2024-12-16 | 88.35 |
| 2024-12-13 | 89.50 |
| 2024-12-12 | 88.73 |
| 2024-12-11 | 90.29 |
| 2024-12-10 | 90.69 |
| 2024-12-09 | 91.14 |
| 2024-12-06 | 93.77 |
| 2024-12-05 | 93.64 |
| 2024-12-04 | 94.12 |
| 2024-12-03 | 92.25 |
| 2024-12-02 | 90.71 |
| 2024-11-29 | 90.21 |
| 2024-11-27 | 89.40 |
| 2024-11-26 | 89.53 |
| 2024-11-25 | 85.63 |
| 2024-11-22 | 84.84 |
| 2024-11-21 | 85.06 |
| 2024-11-20 | 85.45 |
| 2024-11-19 | 82.77 |
| 2024-11-18 | 82.48 |
| 2024-11-15 | 84.63 |
| 2024-11-14 | 89.17 |
| 2024-11-13 | 92.08 |
| 2024-11-12 | 92.88 |
| 2024-11-11 | 94.42 |
| 2024-11-08 | 94.31 |
| 2024-11-07 | 90.45 |
| 2024-11-06 | 88.06 |
| 2024-11-05 | 91.42 |
| 2024-11-04 | 91.43 |
| 2024-11-01 | 92.88 |
| 2024-10-31 | 94.11 |
| 2024-10-30 | 96.05 |
| 2024-10-29 | 102.48 |